The mandate overrules Section 4.1.2 “Civil Rights Protections” of the NIH Grants Policy Statement, which includes the Civil ...

The National Institutes of Health (NIH) is halting new grant and contract payments to several universities, a move the agency ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...

It’s been five years since the U.K.’s breakup with the European Union, and the impacts of extra red tape and rising costs ...

That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...

Tempest Therapeutics is hunkering down to weather the storm that has engulfed its operations. | Tempest Therapeutics is ...

Chico, Vice President and Global Head of Oncology Therapeutic Expertise at Fortrea, shares how scientific advances, AI tools and flexible CRO models are accelerating oncology trials and improving ...

Charles River initially unveiled a plan to adopt new alternative methods (NAMs), like computer models and human organoids, in ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Alis Biosciences has made a pitch to the hundreds of biotechs that are valued at less than the cash they have in the bank.

The U.S. government has pulled the rug out from under Pluri Biotech’s PLX-R18 cell therapy. | The U.S. government has pulled the rug out from under Pluri Biotech’s PLX-R18 cell therapy. Having put up ...

Just a few weeks after closing a $155 million series B, RNA editing biotech AIRNA is bringing an experienced gene therapy ...